Know the Role of Colchicine for Chronic Coronary Disease

December 2023

You’ll hear buzz about new Rx colchicine (Lodoco) for patients with chronic coronary disease.

There’s been growing interest in using colchicine to reduce CV risk...due to its anti-inflammatory effect.

Lodoco is the same drug we use for gout...but it’s 0.5 mg instead of 0.6 mg. And it’s the first colchicine approved to reduce CV risk.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote